MidEuropa, a leading private equity investor with deep roots in Central Europe, announces that its portfolio company, Diagnostyka, a leading provider of medical diagnostic services in Poland, has debuted on the Warsaw Stock Exchange on Friday, February 7, 2025.
The market closing price on the first day of trading puts Diagnostyka s market capitalisation at over €1 billion. Diagnostyka thus ranks as the second-largest publicly listed healthcare services provider in Central Europe and among
Back to media releases (https://norgine.com/media)
Next media release (https://norgine.com/press_release/norgine-receives-positive-chmp-opinion-recommending-approval-of-npj5008-dantrolene-sodium-hemiheptahydrate-for-the-treatment-of-malignant-hyperthermia/)
Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, i
Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee s Oral Delivery of Biologics Platform at the 14th Annual PODD Conference – Partnership Opportunities in Drug Delivery, taking place in Boston, MA, October 28-29, 2024.
Presentation Title: "Breakthrough Device for Oral Delivery of Biologics".